Discovery of novel anticancer flavonoids as potential HDAC2 inhibitors: virtual screening approach based on molecular docking, DFT and molecular dynamics simulations studies-Reference-Cited by-同舟云学术

Discovery of novel anticancer flavonoids as potential HDAC2 inhibitors: virtual screening approach based on molecular docking, DFT and molecular dynamics simulations studies

Published:2024-02-18 Issue:3 Volume:14 Page:
ISSN:2190-572X
Container-title:3 Biotech
language:en
Short-container-title:3 Biotech

Author:

Shah Ashish^ORCID,Choudhary Aarti^ORCID,Jain Manav^ORCID,Perumal Sathiaseelan^ORCID,Patel Vaishali^ORCID,Parmar Ghanshyam^ORCID,Patel Ashish^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13205-023-03912-5.pdf

Reference63 articles.

1. Atahan A, Gencer N, Bilen C, Yavuz E, Genc H, Sonmez F, Zengin M, Ceylan M, Kucukislamoglu M (2018) Synthesis, biological activity and structure-activity relationship of novel diphenylurea derivatives containing tetrahydroquinoline as carbonic anhydrase I and II inhibitors. ChemistrySelect 3(2):529–534. https://doi.org/10.1002/slct.201702562

2. Banerjee P, Eckert AO, Schrey AK, Preissner R (2018) ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 46(W1):W257-w263. https://doi.org/10.1093/nar/gky318

3. Becke AD (1993) A new mixing of Hartree–Fock and local density-functional theories. J Chem Phys 98(2):1372–1377. https://doi.org/10.1063/1.464304

4. BIOVIA DS (2021) Discovery studio 2021 client, San Diego: Dassault Systèmes. Discovery studio

5. Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schiöth HB (2021) Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol 87(12):4577–4597. https://doi.org/10.1111/bcp.14889

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of alpha-glucosidase inhibitors: A comprehensive in silico approach targeting a large set of triazole derivatives;PLOS ONE;2024-09-06

2. In silico exploration of PD-L1 binding compounds: Structure-based virtual screening, molecular docking, and MD simulation;PLOS ONE;2024-08-09

3. Structure‐based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach;Cancer Medicine;2024-08

4. Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B;Molecular and Cellular Biochemistry;2024-06-03

5. Exploring the conformational dynamics and key amino acids in the CD26-caveolin-1 interaction and potential therapeutic interventions;Medicine;2024-05-31